Recent News

• 03.05.2025 - Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
• 02.26.2025 - Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
• 02.18.2025 - Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program

Recent Filings

• 03.04.2025 - 8-K Current report
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - S-3 Registration statement under Securities Act of 1933
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.24.2025 - 8-K Current report
• 01.23.2025 - 8-K Current report
• 01.14.2025 - 8-K Current report